{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Rockford",
      "state": "IL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "70936",
      "recalling_firm": "Mylan Institutional LLC",
      "address_1": "4901 Hiawatha Dr",
      "address_2": "N/A",
      "postal_code": "61103-1287",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-1328-2015",
      "product_description": "Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY  10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL  61103, NDC 67457-467-99.",
      "product_quantity": "a) 15,095 vials  b) 300 vials",
      "reason_for_recall": "Presence of Particulate Matter",
      "recall_initiation_date": "20150318",
      "center_classification_date": "20150813",
      "termination_date": "20160629",
      "report_date": "20150819",
      "code_info": "Lot #: a) 7801082, Exp. 07/15 and b) 7801421, Exp. 09/16"
    }
  ]
}